Posts Tagged: bayh-dole


Increasing the ROI from the Federal Labs

The biggest complaint about federal labs is it's too hard to complete deals. Many federal labs must run pending agreements through byzantine departmental procedures. Companies wonder what's …
By Joseph Allen
5 months ago 6

Unleashing American Innovation, Oil States and Eroom’s Law

NCATS is working with industry to de-risk promising therapies by helping to take them further down the development pipeline. But the key ingredient remains finding a private …
By Joseph Allen
6 months ago 7

Commerce Secretary ready to push update to tech transfer laws to ensure greater commercialization

Secretary Ross gave an unequivocal endorsement of Bayh-Dole specifically, and more generally saying laws need to be updated to address business and technology realities of today, and …
By Gene Quinn
6 months ago 1

Letter to President Trump on China IP Probe is Latest Sign of Conservative Support for Private IP Rights

A group of 16 leaders from politically conservative institutions sent a letter addressed to President Donald Trump lauding the Trump Administration’s decision last summer to initiate an …
By Steve Brachmann
8 months ago 2

Another IP Professor Attack On Patenting

I was just thinking how often someone teaching intellectual property law leads the attack on the patent system when "Racing for academic glory and patents: Lessons from …
By Joseph Allen
11 months ago 21

When Big Brother Comes Marching In: Patent Challenges on Entrepreneurial Campuses

Bayh-Dole has recently come under attack, as some are trying to highjack certain provisions to be used as a cost control measure for novel therapeutics as the …

Pity the Patients if Exclusive Licensing is Undermined

We've learned from experience that just because a theory's off base doesn't mean it won't take root, particularly when it involves patents and medicine. "No Vaccines Before …
By Joseph Allen
12 months ago 1

Think Twice Before Pulling the Plug on Tech Transfer

Most assaults on public/private sector R&D partnerships are launched by those who believe patents are inherently bad and that through some undefined magic publicly funded …
By Joseph Allen
1 year ago 0

Conservatives’ Letter to U.S. Senate Says Preserve Bayh-Dole

Though aimed at certain pharmaceutical products, Sens. Angus King’s and Bernie Sanders’ potential amendments would throw the key to the Bayh-Dole Act’s success —certainty and …
By James Edwards
1 year ago 0

Bernie Sander’s Really Bad Idea

Sen. Bernie Sanders (I-VT) introduced legislation requiring every agency and non-profit entity to include a "reasonable pricing" provision based on King's formula for any life science invention …
By Joseph Allen
1 year ago 14

Proposal from Senator King Won’t Reduce Drug Prices, Just Innovation

Many were stunned to learn that Senator Angus King (I-ME) included language undermining the Bayh-Dole Act in the report of the Senate Armed Services Committee as it …
By Joseph Allen
1 year ago 3

Academic Patent Licensing Helps Drive the U.S. Economy

What's even more impressive is the impacts on gross industry output and GDP are up 14% while  the number of U.S. jobs supported rose 12% since the previous …
By Joseph Allen
1 year ago 8

The Plight of the Public Sector Entrepreneur

Being an entrepreneur isn't easy. While it is a tough road for anyone, it's particularly tough if you're in the public sector and threatened by politicians... Rather, …
By Joseph Allen
2 years ago 1

Early Stage Innovation’s Chance to Save Itself

Universities in particular must explain to their congressional delegations why R&D must continue to be funded and why its Bayh-Dole based commercialization bridge must be protected …
By Chris Gallagher
2 years ago 0

The National Cancer Institute Didn’t Deserve This Treatment From the New York Times

While those in the military are often thanked for their service, let's also thank researchers like Dr. Rosenberg and his colleagues who spend their lives trying to …
By Joseph Allen
2 years ago 2

Our website uses cookies to provide you with a better experience. Read our privacy policy for more information.Accept and Close